$Chemomab Therapeutics(CMMB.US)$Chemomab Reports New Peer-Reviewed Publication Reinforcing The Clinical Association Of Its CCL24 Target With Disease Severity and Mortality In Systemic Sclerosis
Breakthrough in Liver Disease Treatment: Chemomab's CM-101 Secures New European Patent. In the realm of medical science, groundbreaking advancements often mark pivotal moments in the fight against debilitating diseases. One such recent development in the battle against Primary Sclerosing Cholangitis (PSC), a rare and potentially fatal liver disease, has emerged from the labs of Chemomab Therapeutics. The company has been...
$Chemomab Therapeutics(CMMB.US)$Waiting for the rest of the numbers! (((((. Chemomab Therapeutics (NASDAQ:CMMB) reported quarterly losses of $(0.26) per share. This is a 63.89 percent increase over losses of $(0.72) per share from the same period last year. )))))
$Chemomab Therapeutics(CMMB.US)$Chemomab Announces Completion Of Patient Enrollment In CM-101 Phase 2 Primary Sclerosing Cholangitis Trial And Moves Up Expected Topline Readout To Midyear 2024
$Chemomab Therapeutics(CMMB.US)$Well i was hoping when i seen FINTEL was starting to get some shares returned a hour ago. Thought ok now price may go back up? I was wrong, the shares that were returned are already gone again and we are back to zero shares LTB! Grrrrr! Shorts still in control of PA. At least for a bit? Hopefully buy side pressure can increase? GL all
Chemomab Therapeutics股票討論區
In the realm of medical science, groundbreaking advancements often mark pivotal moments in the fight against debilitating diseases. One such recent development in the battle against Primary Sclerosing Cholangitis (PSC), a rare and potentially fatal liver disease, has emerged from the labs of Chemomab Therapeutics. The company has been...
暫無評論